QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)
Close on Nov 17, 2026Market cap $676.84MP/E –Yield –
QuidelOrtho total assets
Total assets on the balance sheet at the end of each period.
QuidelOrtho's total assets was $5.78B at Sep 27, 2026. For fiscal 2025 it was $5.77B, down 10.2% from the year before. The highest annual figure on record is $8.86B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $5.77B | -10.2% |
| FY2024 | Dec 29, 2024 | $6.42B | -25.0% |
| FY2023 | Dec 31, 2023 | $8.56B | -3.3% |
| FY2022 | Jan 1, 2023 | $8.86B | +264.4% |
| FY2021 | Jan 2, 2022 | $2.43B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $5.78B | +1.9% |
| Q2 FY2026 | Jun 28, 2026 | $5.72B | -10.4% |
| Q1 FY2026 | Mar 29, 2026 | $5.63B | -12.9% |
| Q4 FY2025 | Dec 28, 2025 | $5.77B | -10.2% |
| Q3 FY2025 | Sep 28, 2025 | $5.68B | -16.6% |
| Q2 FY2025 | Jun 29, 2025 | $6.38B | -4.6% |
| Q1 FY2025 | Mar 30, 2025 | $6.46B | -3.6% |
| Q4 FY2024 | Dec 29, 2024 | $6.42B | -25.0% |
| Q3 FY2024 | Sep 29, 2024 | $6.80B | -20.4% |
| Q2 FY2024 | Jun 30, 2024 | $6.69B | -21.8% |
| Q1 FY2024 | Mar 31, 2024 | $6.70B | -23.7% |
| Q4 FY2023 | Dec 31, 2023 | $8.56B | -3.3% |
| Q3 FY2023 | Oct 1, 2023 | $8.54B | -1.3% |
| Q2 FY2023 | Jul 2, 2023 | $8.55B | -3.1% |
| Q1 FY2023 | Apr 2, 2023 | $8.79B | +261.5% |
| Q4 FY2022 | Jan 1, 2023 | $8.86B | – |
| Q3 FY2022 | Oct 2, 2022 | $8.66B | – |
| Q2 FY2022 | Jul 3, 2022 | $8.82B | – |
| Q4 FY2021 | Jan 2, 2022 | $2.43B | – |
See a number that looks wrong?